SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Edison International is a renewable energy company, which operates through its subsidiaries. It supplies and distributes electric power, and also invests in energy services and technologies. The company was founded on July 4, 1886, and is headquartered in Rosemead, CA.

Edison International

Edison International is trending following a significant sell-off driven by investor concerns over potential wildfire liability linked to company infrastructure, with the community divided between those bracing for further downside from litigation and those viewing the dip as an attractive entry point for a resilient utility. Sentiment has been recently bolstered by news that the company has identified a homeless encampment near the fire's reported origin, leading some traders to speculate that liability claims may be mitigated.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as traders focus on the anticipated Phase 3 ORIGIN 3 eGFR analysis readout expected in the third quarter. Discussion highlights a divide between investors anticipating a positive catalyst or potential acquisition, and others expressing concern over competition and recent price volatility.

Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, Europe, the Middle East and Africa (EMEA), and Asia-Pacific (APAC). Its brands include Abercrombie and Hollister. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.

Abercrombie & Fitch Co. - Ordinary Shares - Class A

Abercrombie & Fitch Co.

Abercrombie & Fitch is experiencing heavy volatility and high trading volume following a strong earnings report that featured record revenue and raised full-year guidance, though traders remain divided over the extent to which one-time tariff refunds inflated the results. While some investors view the stock as an undervalued cash-generating machine with aggressive buybacks, a vocal group of traders continues to short the stock, labeling it a valuation trap that is overdue for a significant pullback.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending lower as investors digest escalating military tensions between the U.S. and Iran, which have driven oil prices higher and pushed Treasury yields to multi-year peaks. The market remains sensitive to concerns that these inflationary pressures could complicate the Federal Reserve's upcoming rate decision, fueling debates over the sustainability of current equity valuations.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar, and sustainability. The company was founded on November 17, 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PG&E stock is trending following a decline triggered by Bank of America downgrading the company and slashing its price target after California wildfire legislation failed to pass. While some retail traders remain bullish and view the drop as an overreaction, others are concerned about unresolved wildfire liability risks and potential impacts on the company's long-term capital plans.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending due to rising oil prices fueled by escalating geopolitical tensions in the Middle East, particularly following recent U.S. military strikes near the Strait of Hormuz. Community discussion is characterized by intense debate between traders banking on further price increases and those speculating that the rally is a manipulation or unsustainable.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing heightened volatility and mixed sentiment as traders balance concerns over valuation and guidance with anticipation for the upcoming earnings report. The conversation reflects a divide between those concerned about competitive pressure in the AI connectivity market and those who view the stock as undervalued, betting that strong AI-driven revenue will catalyze a rebound.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is trending as investors monitor ongoing geopolitical instability in the Strait of Hormuz, which continues to drive volatility in oil prices and fuel inflation concerns. While some traders are capitalizing on sector strength and potential breakout patterns, others remain cautious regarding long-term supply disruptions and the sustainability of recent energy sector performance.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

A hawkish Federal Reserve message from Kevin Warsh pushed Treasury yields and rate-hike expectations higher, pressuring gold and triggering a sharp pullback in gold miners. Traders are divided between those expecting further correction after an overbought rally and longer-term bulls who view debt, inflation, Treasury intervention, and potential rate cuts as supportive for precious metals.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

A strong fiscal Q4 beat and raised outlook have focused attention on Seagates AI- and cloud-driven mass-storage demand, with HAMR technology and tight HDD supply supporting expectations for continued margin growth. Traders remain divided, with bulls viewing the results as evidence of a durable storage upcycle while bears point to elevated valuation, sector-wide deleveraging, and cyclical risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Axsome Begins Phase III Study on AXS-05 for Smoking Cessation

AXSM begins dosing in the phase III SUMMIT study investigating AXS-05 for treating smoking cessation in adults.

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAmgen is a diversified pharmaceutical giant with high net margins. It reported nearly $8.1 billion in free cash flow for fiscal 2025...

Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run

Key PointsAxsome Therapeutics is performing well as it continues to expand its approved portfolio...

If You Invested $100 In Axsome Therapeutics Stock 10 Years Ago, You Would Have This Much Today

Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 10 years by 26.64% on an annualized basis producing an average annual return of 40.19%. Currently, Axsome Therapeutics has a marketread more...

Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y Revenues

AXSM's Q2 earnings meet estimates, but revenues miss forecasts. Auvelity and other product sales drive year-over-year revenues.

AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030  

Equity

The FDA has already accepted the company’s application seeking the greenlight for AXS-12.


Axsome (AXSM) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Axsome (AXSM) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Axsome Therapeutics (AXSM) Reports Q2 Loss, Misses Revenue Estimates

Axsome (AXSM) delivered earnings and revenue surprises of 0.00% and -2.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Alpha Cognition Inc. (ACOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates

Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of +56.52% and +98.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

• Reported GAAP EPS of -$0.99 down -2.06% YoY
• Reported revenue of $218.38M up 45.54% YoY
• Axsome Therapeutics believes that its current cash is sufficient to fund anticipated operations into cash flow positivity, based on the current operating plan, though no specific financial targets were provided.

Axsome Therapeutics experienced an increased net loss and significantly higher operating expenses during the second quarter of 2026, while the company faces ongoing regulatory uncertainty regarding its pipeline product AXS-12.

Axsome Therapeutics delivered robust year-over-year revenue growth driven by strong AUVELITY performance and successful commercial expansion, while the company continues to advance its innovative neuroscience pipeline toward key upcoming milestones.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

AXSM Axsome Therapeutics Inc

Fundamentals

Latest AXSM News